1 |
Abbas, A. K., A. H. Lichtman, and J. S. Pobe. 1994. Cytokines, p. 240. In Cellular and Molecular Immunology. 2nd Ed. W. B. Saunders Co., Philadelphia, PA
|
2 |
Choi, Y J., C. J. Kim, S. Y Park, Y T. Ko, H. K. Jeong, and G E. Ji. 1996. Growth and beta-glucosidase activity of Bifidobacterium. J. Microbiol. Biotechnol. 6: 255-259
|
3 |
Kanauchi, O., K. Mitsuyama, Y Araki, and A. Andoh. 2003. Modification of intestinal flora in the treatment of int1ammatory bowel disease. Curr. Pharm. Res. 9: 336-346
|
4 |
Lammers, K. M., P. Brigidi, B. Vitali, P. Gionchetti, F. Rizzello, E. Caramelli, D. Matteuzzi, and M. Campieri. 2003. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 38: 165-172
DOI
ScienceOn
|
5 |
Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241
DOI
ScienceOn
|
6 |
Rafter, J. J. 1995. The role of lactic acid bacteria in colon cancer prevention. Scand. J. Gastroenterol. 30: 497-502
DOI
PUBMED
ScienceOn
|
7 |
Sekine, K., E. Watanabe-Sekine, J. Ohta, T. Toida, T. Tatsuki, T. Kawashima, and Y. Hashimoto. 1994. Induction and activation of tumoricidal cells in vivo and in vitro by the bacterial cell wall of Bifidobacterium infantis. Bifidobact. Microfl. 13: 65-77
DOI
|
8 |
Yasui, H. and M. Ohwaki. 1991. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J. Dairy Sci. 74: 1187-1195
DOI
ScienceOn
|
9 |
Sekine, K., J. Ohta, M. Onishi, T. Tatsuki, Y. Shimokawa, T. Toida, T. Kawashima, and Y. Hashimoto. 1995. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium in/antis. Biol. Pharm. Bull. 18: 148-153
DOI
ScienceOn
|
10 |
Mitsuoka, T. 1982. Recent trends in research on intestinal flora. Bifidobact. Microfl. 1: 3-24
DOI
|
11 |
Strober, W. 1991. Trypan blue exclusion test for cell viability, pp. A.3.3-4.ln J. E. Coligan, A. M. Kruisbeek, D. H. Marguiles, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology. Greene Pub. and Wiley-Interscience, New York, U.S.A,
|
12 |
Park, M. S., H. W. Moon, and G. E. Ji. 2003. Molecular characterization of plasmid from Bifidobacterium longum. J. Microbial. Biotechnol. 13: 457-461
|
13 |
Fernandes, C. F. and K. M. Shahani. 1990. Anticarcinogenic and immunological properties of dietary lactobacilli. J. Food Proto 53: 704- 710
DOI
|
14 |
Gomez, E., M. M. Melgar, G P. Silva, A Portoles, and I. Gil. 1988. Exocellular products from Bifidobacterium adolescentis as immunomodifiers in the Iymphoprohferative responses of mouse splenocytes. FEMS Microbiol. Lett. 56: 47-52
DOI
|
15 |
Kim, H. J., J. H. Kim, J. H. Son, H. J. Sea, S. J. Park, M. S. Paek, and S. K. Kim. 2004. Characterization of bacteriocin produced by Lactobacillus bulgaricus. J. Microbiol. Bioteclmol. 14: 503-508
|
16 |
Sasaki, T., S. Fukami, and S. Namioka. 1994. Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobacterium thermophilum. J. Vet. Med. Sci. 53: 433-437
|
17 |
Yu, K. W., K. S. Shin, Y. M. Choi, and H. J. Suh. 2004. Macrophage stimulating activity of exo-biopolymer from submerged culture of Lentinus edodes with rice bran. J. Microbiol. Biotechnal. 14: 658-664
|
18 |
Lee, J., A. Ametani, A. Enomoto, Y. Sato, H. Motoshima, F. Ike, and S. Kaminogawa. 1993. Screening for the immunopotentiating activity of food microorganisms and enhancement of the immune response by Bifidobacterium adolescentis M101-4. Biosci. Biotech. Biochem. 57: 2127-2132
DOI
|
19 |
Namioka, S. 1985. Immunoresponsiveness of newborn piglets and peptidoglycan derived from Bifidobacterium. Bifidobact. Microfl. 4: 3-14
DOI
|
20 |
Hattori, K., A. Yamamoto, M. Sasai, S. Taniuchi, T. Kojima, Y Kobayashi, H. Iwamoto, K. Namba, and T. Yaeshima. 2003. Effects of administration of bifidobacteria on fecal microtlora and clinical symptoms in infants with atopic dermatitis. Arerugi 252: 20-30
|
21 |
Hughes, D. B. and D. G Hoover. 1991. Bifidobacterium: Their potential for use in American dairy products. Food Technol. 45: 74-83
|
22 |
Hatcher, G E. and R. S. Lambrecht. 1993. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J. Dairy Sci. 76: 2485-2492
DOI
ScienceOn
|
23 |
Dong, W., J. I. Azcona-Olivera, K. H. Brooks, J. E. Linz, and J. J. Pestka. 1994. Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma. Toxicol. Appl. Pharmacol. 127: 282-290
DOI
ScienceOn
|
24 |
Hosono, A, J. Lee, A Ametani, M. Natsume, M. Hirayama, T. Adachi, and S. Kaminogawa. 1997. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterim adolescentis M 101-4. Biosci. Biotech. Biochem. 61: 312-316
DOI
ScienceOn
|
25 |
Ishikawa, H., I. Akedo, Y. Umesaki, R. Tanaka, A. lmaoka, and T. Otani. 2003. Randomized controlled trial ofthe effect of Bifidobacterium-fermented milk on ulcerative colitis. J. Am. Call. Nutr. 22: 256-263
|
26 |
Kim, I. H., M. S. Park, and G E. Ji. 2003. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocytelike Caco-2 cells. J. Microbiol. Biotechnol. 13: 276-281
|
27 |
Miettinen, M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human necrosis factor alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64: 5403-5405
|
28 |
Kado-Oka, Y, S. Fujiwara, and T. Hirota. 1991. Effects of Bifidobacterium cells on mitogenic response of splenocytes and several functions of phagocytes. Milchwissenshaft 46: 626-630
|
29 |
Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54: 1-78
DOI
|